Sentient Synthetics
AI-based Digital Pathology Solutions
Company Overview
Snapshot
Founded in May 2021 by Prof. Yonatan (Yoni) Savir, Sentient Synthetics operates with 1–10 employees. The company has raised $250,000 across one funding round from aMoon Fund. In September 2021, Sentient Synthetics was selected for the Starfinder Lab program by aMoon and Roche.
Business overview
Sentient Synthetics is an AI-based digital pathology company that develops solutions to overcome data limitations in computational pathology. The company leverages machine learning to create synthetic pathology datasets that are validated, affordable, thoroughly labeled, and free from privacy concerns. These datasets enable faster and more accurate training and validation for highly accurate AI algorithms, serving medical research centers, digital health companies, pharmaceutical companies, and diagnostics providers across all cancer tissue types, including rarer forms. Sentient Synthetics operates within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Digital Medical Diagnostics.
Strategic signal
In September 2021, Sentient Synthetics was selected for the Starfinder Lab program by aMoon and Roche. This selection signals strong early validation for the company's AI-based digital pathology solutions, indicating recognition from key players in the health tech and pharmaceutical industries regarding the potential of synthetic datasets to address critical data challenges in cancer diagnostics and research.
Company Intelligence Q&A
- What is Sentient Synthetics' primary focus?
- Sentient Synthetics focuses on developing AI-based digital pathology solutions that utilize machine learning to create synthetic pathology datasets. These datasets aim to overcome existing data limitations in computational pathology for various cancer tissue types.
- When was Sentient Synthetics founded?
- Sentient Synthetics was founded in May 2021.
- Who is a founder of Sentient Synthetics?
- Prof. Yonatan (Yoni) Savir is a founder and CSO of Sentient Synthetics.
- What significant program was Sentient Synthetics selected for?
- In September 2021, Sentient Synthetics was selected for the Starfinder Lab program by aMoon and Roche.
- What is the total disclosed funding raised by Sentient Synthetics?
- Sentient Synthetics has raised a total of $250,000 in a Pre-Seed round in September 2021 from aMoon Fund.